Can Crohn's disease cause hair loss?

Can Crohn's Disease Cause Hair Loss?

Yes, Crohn's disease can cause hair loss through multiple mechanisms including disease-related inflammation (telogen effluvium), nutritional deficiencies, medication side effects, and shared autoimmune pathways with alopecia areata.

Mechanisms of Hair Loss in Crohn's Disease

Disease-Related Hair Loss (Telogen Effluvium)

The most common form of hair loss in Crohn's disease is telogen effluvium, which occurs during acute or chronic disease flares 1. This stress-induced hair loss results from the systemic inflammatory burden of active disease. Notably, telogen effluvium can even precede gastrointestinal symptoms—one case documented a child presenting with hair loss one year before Crohn's diagnosis, with hair loss improving after disease remission and recurring with relapse 2.

Nutritional Deficiencies

Crohn's disease frequently causes malnutrition through limited food intake, malabsorption, and increased nutrient losses 3. Iron deficiency is particularly common and directly contributes to hair loss 3. Other deficiencies that can cause alopecia include zinc, folic acid, vitamins B12, D, and protein-calorie malnutrition 3. These deficiencies are more pronounced in patients with active disease, extensive small bowel involvement, or prior intestinal resections.

Autoimmune Association with Alopecia Areata

There is a significantly increased prevalence of alopecia areata (AA) in Crohn's patients compared to the general population (0.63% vs 0.1%, p<0.0001) 4. This association reflects shared genetic risk factors and overlapping immune dysregulation pathways, particularly involving interferon-γ and JAK signaling 4, 5. The pooled prevalence of non-scarring alopecia among IBD patients is 1.12% 4.

Medication-Induced Hair Loss

Several Crohn's medications can cause hair loss 1:

• Methotrexate and sulfasalazine interfere with folate metabolism
• Corticosteroids can cause telogen effluvium
• Anti-TNF agents (infliximab, adalimumab) paradoxically can trigger new-onset alopecia areata in some patients 6, 7
• Cyclosporine causes hirsutism (excessive hair growth), not hair loss 8

Clinical Approach to Hair Loss in Crohn's Patients

Assessment

When evaluating hair loss in a Crohn's patient, systematically exclude:

1. Nutritional deficiencies: Check CBC (iron deficiency anemia), ferritin, vitamin B12, folate, zinc, albumin, and vitamin D 3
2. Disease activity: Assess inflammatory markers (CRP, fecal calprotectin), symptoms, and consider endoscopic evaluation
3. Medication review: Identify temporal relationship between drug initiation and hair loss onset
4. Thyroid function: Rule out concurrent autoimmune thyroid disease
5. Pattern of hair loss: Diffuse thinning (telogen effluvium) versus patchy loss (alopecia areata) versus scarring patterns

Management Strategy

For telogen effluvium related to active disease:

• Optimize Crohn's disease control to achieve remission—hair regrowth typically follows disease remission 2
• Address nutritional deficiencies aggressively with supplementation
• Reassure patients that hair typically regrows 3-6 months after the inflammatory trigger resolves

For nutritional deficiency-related hair loss:

• Correct specific deficiencies (iron is most critical) 3
• Consider nutritional screening and assessment by a multidisciplinary team 3
• In severe malnutrition, enteral or parenteral nutrition may be necessary 9

For medication-induced hair loss:

• If methotrexate-related: ensure adequate folic acid supplementation (daily dosing) 10
• If anti-TNF-related alopecia areata develops: consider switching to alternative mechanism biologics or JAK inhibitors 6, 7

For concurrent alopecia areata:

• JAK inhibitors (tofacitinib, upadacitinib) can treat both Crohn's disease and alopecia areata simultaneously 6, 7
• One case demonstrated complete remission of alopecia universalis following colectomy for refractory Crohn's, suggesting that addressing the primary intestinal inflammation can resolve the autoimmune hair loss 5

Important Caveats

• Hair loss severity does not necessarily correlate with Crohn's disease severity—even well-controlled disease can have associated alopecia areata due to shared autoimmune mechanisms
• The rapid development of severe hair loss warrants investigation for other causes beyond Crohn's disease
• Drug-induced alopecia from anti-TNF agents is rare but increasingly recognized; this represents a paradoxical inflammatory reaction rather than treatment failure
• Patients with one autoimmune condition (Crohn's) are at higher risk for developing additional autoimmune conditions (alopecia areata), independent of disease activity

Screen all Crohn's patients with hair loss for nutritional deficiencies and assess disease activity before attributing hair loss solely to medications or coincidental causes 3, 1.